新型药物 ganaxolone 治疗发作的疾病
Selia Chowdhury1, Samia Chowdhury2
1Dhaka Medical College, Dhaka, Bangladesh.
Discoveries (Craiova, Romania)
|August 11, 2025
概括
类固醇是一种神经活性类固醇,显示出降低患者发作频率的潜力. 虽然一般有效,但与治疗相关的不良事件,如头和昏昏欲睡,需要进一步的安全性和疗效研究.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 加纳克索隆是一种神经活性类固醇,已知可以增强GABAergic抑制.
- 是一种神经系统疾病,其特点是经常性发作.
研究的目的:
- 系统地审查 ganaxolone 对发作的疗效和安全性.
- 评估加纳克索隆在各种性疾病中的整体益处.
主要方法:
- 随机对照试验 (RCT) 系统综述公布至2023年3月.
- 搜索数据库:PubMed,谷歌学者,欧洲PubMed中央,柯克伦图书馆和美国国家医学图书馆临床试验.
- 包括12个RCT,涉及1337名患者.
主要成果:
- 所有试验中的26.3%的参与者报告说,发作频率减少了50%以上.
- 与治疗相关的不良事件 (TRAEs) 影响神经系统最多.
- 常见的TRAE包括头,嗜睡,头痛和发作.
结论:
- 加纳克索隆在降低患有特定类型的患者的发作频率方面表现出潜在的有效性,包括CDKL5缺乏症,伦诺克斯-加斯托综合征和Protocadherin 19.
- 需要进一步的研究来证实ganaxolone在更广泛的患者群体中的安全性和有效性.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
276
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
276
Antiepileptic Drugs: GABAergic Pathway Potentiators
646
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
646
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
448
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
448
Antiepileptic Drugs: Glutamate Antagonists
516
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
516
Anxiolytic Drugs: Overview
485
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
485
Epilepsy and Seizures: Overview
280
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
280


